We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

DIASYS DIAGNOSTIC SYSTEMS

Develops, manufactures, and distributes diagnostic systems for clinical chemistry and immunoturbidimetry. Supplies hi... read more Featured Products: More products

Download Mobile App





DiaSys Showcases High Quality Clinical Chemistry Solutions at WHX Labs Dubai

By LabMedica International staff writers
Posted on 10 Feb 2026

At WHX Labs Dubai 2026, DiaSys Diagnostic Systems GmbH (Holzheim, Germany) is presenting a comprehensive portfolio of diagnostic solutions focused on clinical chemistry and immunoturbidimetry. More...

Exhibiting at booth S2.E50, the company highlights more than three decades of experience supplying laboratories in over 140 countries worldwide. Visitors to the company's booth can experience live demonstrations and learn about DiaSys's latest innovations that support laboratories throughout the world.

At its booth, DiaSys showcases its instrumentation portfolio of automated clinical chemistry analyzers that provide efficient and reliable testing options for small to medium-sized laboratories. This includes the respons® c-line series, featuring the respons® 240c, respons® 420c, and respons® 600c analyzers. In addition, the portfolio includes dedicated systems such as the respons® A1c for HbA1c testing and the respons® UDS100 for urine diagnostics.

DiaSys is also highlighting its broad portfolio of more than 90 ready-to-use reagents, spanning routine clinical chemistry, lipid testing, liver and kidney function, coagulation-related markers, inflammatory biomarkers, and specialized immunoturbidimetric assays. The reagent range is complemented by calibrators and controls, enabling complete, traceable, and quality-assured system solutions for clinical laboratories.

The portfolio is further supported by DiaSys’s TruCal® calibrators and TruLab® quality control materials, which support standardized workflows, traceability, and consistent analytical performance across clinical chemistry testing.

Related Links: 
DiaSys Diagnostic Systems

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Mayo Clinic researchers used genetic data from nearly 50,000 participants to identify sickle cell and beta-thalassemia carrier traits, highlighting how population-scale testing can complement existing screening (Image Credit: Adobe Stock)

Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more

Pathology

view channel
Image Credit: Adobe Stock

AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification

In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.